Taking Aim At Superbugs

Join us with our guest, Professor Simon Cutting, Ph. D., as we discuss the genetic control of spore formation in Bacillus subtilis, and the research behind the scenes defining Clostridioides difficile in health and environment.

Join us with our guest, Ron Roman, RN, CEO Safety Net as we discuss creating a safe environment, maintaining a safe environment in both healthcare and home. Ron will review Disinfection – what is Clean, Sanitize, Disinfect and Sterilize and how to simplify the terms.

Join us with three C. diff. Survivors - Christine, Alba, and Renata, as they share their personal message with you. We are grateful for their time and for sharing their C. diff. infection experiences with us.

A Symposium specifically developed for Patients Diagnosed With a C. diff. Infection, Being Treated For a Clostridioides diffiicile infection, Recovering From a Clostridioides difficile Infection and Recurrences with Family Members and Caregivers. Distinguished members and keynote speakers provide insight as to what impacts the patient and families on both quality and economic topics, what role leadership plays in creating the right culture for patient-centered care, and how to identify, evaluate, and prioritize innovations that can quickly touch the lives of patients battling C. diff. infections. Kathy Bischoff, C. diff. Survivor My C. diff. Journey Renata Johnson, C. diff. Survivor My C. diff. Journey Paul Feuerstadt, MD - review Barbara McGovern, MD, “Treatment of recurrent C. difficile infection with SER-109, an investigational microbiome drug.

A Symposium specifically developed for Patients Diagnosed With a C. diff. Infection, Being Treated For a Clostridioides diffiicile infection, Recovering From a Clostridioides difficile Infection and Recurrences with Family Members and Caregivers. Distinguished members and keynote speakers provide insight as to what impacts the patient and families on both quality and economic topics, what role leadership plays in creating the right culture for patient-centered care, and how to identify, evaluate, and prioritize innovations that can quickly touch the lives of patients battling C. diff. infections. Courtney Jones ” Microbiome, Microbiota, and Gut Health.” Denise Cardo, MD “Everyone Has a Role in Antibiotic Awareness.” Larry Kociolek, MD “C. diff. Infections in Pediatrics.” This event was sponsored by Seres Therapeutics. Seres Therapeutics mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics Enjoy the program!

Welcome to the second episode of a special four (4) part series: A Symposium Created For Patients Diagnosed With a C. diff. Infection, Being Treated For a Clostridioides diffiicile infection, Recovering From a Clostridioides difficile Infection and Recurrences with Family Members and Caregivers. Welcome to a Symposium specifically developed for patients, families, and caregivers. The Patient & Family C. diff. Symposium: where a gathering of healthcare professionals, keynote speakers, health advocates, practitioners, educators, are transforming the patient experience, and changing the way people experience C. diff. infections worldwide. Simon Cutting, Ph. D. “Bacillus, and C. diff. Spore Overview. “ Teena Chopra, MD ” Introduction to Infection Prevention.” Doe Kley, RN, MPH “C. diff. Transitioning from Hospital to Home. This event was sponsored by Seres Therapeutics, Seres Therapeutic's mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics Enjoy the presentations by the topic leaders joining us!

The Patient & Family C. diff. Symposium: A gathering of healthcare professionals, keynote speakers, health advocates, practitioners, educators, thought leaders, and patients who are transforming the patient experience, and changing the way people experience C. diff. infections worldwide. Program Presenter: Paul Feuerstadt, MD, FACG Barbara McGovern, MD “Treatment of recurrent C. difficile infection with SER-109, an investigational microbiome drug.” Paul Feuerstadt, MD ” C. diff. Overview – What is a C. diff. Infection?” Sahil Khanna, MBBS, “C. diff. Treatments and FMT Overview. “

Dr. Tamas Haidegger, Ph. D., Associate Professor Obuda University, and Co-founder: HandInscan will be discussing the importance of not only hand-washing but how Hand Hygiene is the top priority in social safety. Hand Hygiene remains the number one infection prevention action individuals can utilize worldwide to prevent the spread of germs and viruses worldwide. Dr. Haidegger will also introduce the research and science behind the HandInScan - an objective hand hygiene control in the medical environment.

Join us with our guest Dr. Robert Carman, Ph. D., Director of Microbiology at TECHLAB, Inc. Dr. Carman's research focuses on Clostridioides difficile (C. diff., C. difficile, CDI). Dr. Carman not only introduces us to the gut microbiome, but explains the details of the environment, the colonies of microorganisms, bacteria, viruses, protozoa, and fungi, that are present in the gastrointestinal tract

Metronidazole For the Treatment of C. difficile Infections: On the Way Out? - Presented by: Wiep Klaas Smits, Ph. D., Department of Medical Microbiology Leiden University Medical Center. A Four-pronged Threat: Clostridioides difficile Infection (CDI), Antibiotics, the Flu Season, and COVID-19.” - Presented by: Dr. David Lyerly, Co-founder and Chief Science Officer of TECHLAB, Inc. Aerosol Transmission of Pathogens: The Problem and the Solutions. Presented by: Maureen Spencer, RN, M.ED., CIC